It is with profound sadness that we share the passing of Rebecca Lambert Bent, Founder, President, and Executive Chair of NED Biosystems, who died peacefully and surrounded by her family on August 11 following a short illness.
Rebecca worked passionately and, with her characteristic tenacity, sought to advance a systems-based approach to cancer treatment globally. As President and CEO, she led the development of the company’s oral cancer protocol, NED-170, and guided NED-170 through crucial preparation for its clinical trial. Her vision was shaped by decades of entrepreneurial, civic, and public service leadership, and by her commitment to addressing late-stage cancers in a fundamentally different way.
Those within Rebecca’s magnetic orbit knew her as a determined and original thinker whose energy, conviction, and ability to bring people together helped build the foundation on which the company stands today. Her work with respected scientific leaders, including her original mentor Judah Folkman, MD, and more recently DNA sequencer inventor LeRoy Hood, MD, PhD, among others, reflected both her ambition for NED and her belief that meaningful progress in treating complex diseases requires collaboration across disciplines.
On behalf of the entire NED team and Board, we extend our deepest condolences to Rebecca’s family and all who knew and loved her.
We remain committed to honoring Rebecca’s legacy by continuing the work she began with care, discipline, and purpose. NED’s Board has confirmed effective immediately that the Company’s leadership roles are as follows: Geoffrey Ling, MD, PhD, Col (Ret) is Chair of the Board of Directors; José Miguel Trevejo, MD, PhD is serving as Interim CEO; Elinor Mullins is President; and Mary Davis is Treasurer.
As we seek to realize Rebecca’s vision that all cancer patients have access to treatment that provides quality-of-life, lacks toxicity, and allows them to remain productive members of their community, we are more dedicated than ever to advancing NED-170 into its phase 2a clinical trial on a path that honors her hard work.
A longtime resident of Washington, CT, and summer resident of Nantucket, MA, Rebecca was born in Binghamton, NY, daughter of Dr. Abol Hassan and Eleanor Fotouhi.
She attended Williams College and graduated from Simmons College with a bachelor’s degree in political science in 1969. She completed Harvard Business School’s advanced management program in 1982, where she was the sole woman in her class and also ran the Boston Marathon.
She was a longtime congregant and vestry member of St. John’s Church, in Washington, CT, and St. Paul’s Church on Nantucket.
She leaves her husband Ted, her son, Max (Holly) of Richmond, VA, and their two children, and a daughter, Insha Afsar.
Rebecca founded NED Biosystems, a public benefit corporation, to develop her unique systems-approach to cancer treatment which is now preparing for a clinical trial.
Earlier in her political and entrepreneurial career, in 1985 Rebecca acquired five FM radio stations and upgraded each to become Top-100 market properties.
Then, in 1988 she founded Lambert Communications, creating what became the largest multi-channeled, broadcast satellite network serving U.S. hospitals. Subsequently in 2001 she led funds acquisition for Shaker Investments to $1 billion under management.
Prior to these entrepreneurial initiatives, Rebecca began her career managing grass-roots political strategy for statewide campaigns, first in Vermont and then in Wyoming for Senator Malcolm Wallop’s upset victory in 1976, after which she served as chief of staff for both Senator Ted Stevens’ national Republican senatorial committee and for Senator Wallop. Subsequently she was appointed deputy assistant secretary, Department of Energy; and then associate deputy secretary, Department of Commerce, where she initiated the federal government’s first use of a memorandum of understanding related to Brazilian hydro projects.
In the civic sector, Rebecca was president of the Bellevue Hospital Association in New York; an associate trustee of the NYU Medical Center Board; and a member of both the Harvard Women’s Leadership Board and the Women’s Forum of New York.


